The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation

Introduction: circulating miRNA were identified as potential biomarkers in cardiac arrhythmias. It is intended to evaluate, in patients with atrial fibrillation (AF), the expression of miRNAs in plasma, their clinical repercussion and their prognostic factor. Materials and Methods: PubMed, Cochrane...

Full description

Bibliographic Details
Main Authors: Kamilo Mesquita Dantas, Heitor Tomé Rezende, Antônio Menezes da Silva Junior, Hermínio Sobrinho, Pedro Paulo Clark de Oliveira
Format: Article
Language:English
Published: Linceu Editorial 2020-04-01
Series:Journal of Cardiac Arrhythmias
Subjects:
Online Access:https://www.jca.org.br/jca/article/view/3374
_version_ 1818517718442180608
author Kamilo Mesquita Dantas
Heitor Tomé Rezende
Antônio Menezes da Silva Junior
Hermínio Sobrinho
Pedro Paulo Clark de Oliveira
author_facet Kamilo Mesquita Dantas
Heitor Tomé Rezende
Antônio Menezes da Silva Junior
Hermínio Sobrinho
Pedro Paulo Clark de Oliveira
author_sort Kamilo Mesquita Dantas
collection DOAJ
description Introduction: circulating miRNA were identified as potential biomarkers in cardiac arrhythmias. It is intended to evaluate, in patients with atrial fibrillation (AF), the expression of miRNAs in plasma, their clinical repercussion and their prognostic factor. Materials and Methods: PubMed, Cochrane and Google Scholar platforms were used as a data source. Eligibility criteria: miRNAs as direct biomarkers in the clinical expression of AF; all languages. Last search: 19/09/2019; studies involving other comorbidities were excluded; pharmacological focus; in animals, in patients already submitted to cardiac procedures and review articles. Plasma collection and storage, RNA isolation, data analysis, realtime PCR, miRNA target prediction and statistical analysis were performed in the studies. Results: The studies generated n = 332 patients: with AF and control group. In patients with AF there was an increase in the expression of miR-1266, miR-4279, miR- 892a, miR-3149, miR-155, miR-146b5p, miR-19b and a reduction in miR-3171, miR-3664-5p and miRNA -150. Discussion: it was noted that the regulation of inflammatory mediators, ion channels and cardiac morphophysiology are related to the expression of miRNA. Conclusion: Therefore, the levels of changes in miRNAs may reflect the severity of the clinical and pathophysiological progression of AF, and can be used as predictors of AF.
first_indexed 2024-12-11T01:00:05Z
format Article
id doaj.art-729242cff34e41d29a5fe088fb5ba101
institution Directory Open Access Journal
issn 2674-7472
language English
last_indexed 2024-12-11T01:00:05Z
publishDate 2020-04-01
publisher Linceu Editorial
record_format Article
series Journal of Cardiac Arrhythmias
spelling doaj.art-729242cff34e41d29a5fe088fb5ba1012022-12-22T01:26:22ZengLinceu EditorialJournal of Cardiac Arrhythmias2674-74722020-04-01324The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial FibrillationKamilo Mesquita Dantas0Heitor Tomé Rezende1Antônio Menezes da Silva Junior2Hermínio Sobrinho3Pedro Paulo Clark de Oliveira4Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil.Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil.Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil.Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil.Pontifícia Universidade Católica de Goiás – Escola de Ciências Médicas, Farmacêuticas e Biomédicas Goiânia (GO), Brazil.Introduction: circulating miRNA were identified as potential biomarkers in cardiac arrhythmias. It is intended to evaluate, in patients with atrial fibrillation (AF), the expression of miRNAs in plasma, their clinical repercussion and their prognostic factor. Materials and Methods: PubMed, Cochrane and Google Scholar platforms were used as a data source. Eligibility criteria: miRNAs as direct biomarkers in the clinical expression of AF; all languages. Last search: 19/09/2019; studies involving other comorbidities were excluded; pharmacological focus; in animals, in patients already submitted to cardiac procedures and review articles. Plasma collection and storage, RNA isolation, data analysis, realtime PCR, miRNA target prediction and statistical analysis were performed in the studies. Results: The studies generated n = 332 patients: with AF and control group. In patients with AF there was an increase in the expression of miR-1266, miR-4279, miR- 892a, miR-3149, miR-155, miR-146b5p, miR-19b and a reduction in miR-3171, miR-3664-5p and miRNA -150. Discussion: it was noted that the regulation of inflammatory mediators, ion channels and cardiac morphophysiology are related to the expression of miRNA. Conclusion: Therefore, the levels of changes in miRNAs may reflect the severity of the clinical and pathophysiological progression of AF, and can be used as predictors of AF. https://www.jca.org.br/jca/article/view/3374BiomarkersAtrial FibrillationMicroRNAs
spellingShingle Kamilo Mesquita Dantas
Heitor Tomé Rezende
Antônio Menezes da Silva Junior
Hermínio Sobrinho
Pedro Paulo Clark de Oliveira
The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation
Journal of Cardiac Arrhythmias
Biomarkers
Atrial Fibrillation
MicroRNAs
title The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation
title_full The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation
title_fullStr The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation
title_full_unstemmed The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation
title_short The Clinical Expression and Implication of Plasma miRNAs in Patients with Atrial Fibrillation
title_sort clinical expression and implication of plasma mirnas in patients with atrial fibrillation
topic Biomarkers
Atrial Fibrillation
MicroRNAs
url https://www.jca.org.br/jca/article/view/3374
work_keys_str_mv AT kamilomesquitadantas theclinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT heitortomerezende theclinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT antoniomenezesdasilvajunior theclinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT herminiosobrinho theclinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT pedropauloclarkdeoliveira theclinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT kamilomesquitadantas clinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT heitortomerezende clinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT antoniomenezesdasilvajunior clinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT herminiosobrinho clinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation
AT pedropauloclarkdeoliveira clinicalexpressionandimplicationofplasmamirnasinpatientswithatrialfibrillation